Medical Devices Startups

Synergy Spine Solutions develops motion-preserving medical devices for patients undergoing spine surgery to treat degenerative disc disease. The company's FDA-approved flagship product, the Synergy Disc, features a built-in lordotic core designed to preserve spinal motion and improve alignment.

1 investor

Synex develops compact, portable technology that uses magnetic resonance spectroscopy to measure blood metabolites such as glucose and lactate non-invasively and in real time, without a needle prick. The company is building non-invasive health monitoring devices aimed at enabling predictive healthcare.

1 investor

Artis BioSolutions is an integrated platform for genetic medicine that produces enzymatically synthesized synthetic DNA and develops it into clinical-grade advanced therapies with in-house GMP manufacturing. It serves developers of advanced therapy medicinal products across modalities such as mRNA, gene editing, viral vectors, cell therapies, and vaccines, with production sites in Watertown, MA (US) and Bilbao, Spain (EU).

1 investor

SYNLAB provides medical diagnostic and laboratory testing services covering disease prevention, diagnosis, treatment monitoring, and follow-up for patients and the medical community. It operates through a network of specialists across more than 20 countries.

1 investor

Synokem is a pharmaceutical contract manufacturing and supply company offering branded and institutional medical products through its own manufacturing, quality, and distribution capabilities.

1 investor

Synoro Med designs and operates a reusable container system for medical fluids like intravenous solutions, paired with regional reprocessing services to clean and sterilize containers for safe reuse in healthcare settings. The company serves healthcare providers seeking to reduce single-use plastic waste and supply chain dependency while maintaining cost parity with traditional disposable alternatives.

1 investor

Synova Life Sciences develops technology for biomedical applications, focusing on innovative solutions in the life sciences sector.

1 investor

SynOx Therapeutics develops emactuzumab, a monoclonal antibody treatment for tenosynovial giant cell tumours (TGCT) and macrophage-mediated diseases. The company focuses on bringing a differentiated drug candidate through clinical development and commercialisation to address unmet patient needs in rare and debilitating diseases.

1 investor

SynThera develops bioactive glass-based biomaterials and specialty glass products for healthcare, industrial, and consumer applications including bone tissue regeneration, dental repair, skincare, and technical glass for electronics and aerospace. The company serves pharmaceutical, medical device, cosmetics, FMCG, and industrial sectors with a focus on high-purity glass materials.

1 investor

Synthetic Design Lab develops engineered therapeutic platforms and AI-driven antibody design technologies for precision medicine and cancer immunotherapy. The company builds protein engineering and antibody drug conjugate solutions for pharmaceutical development.

1 investor

SynVaccine develops technology for the computer-aided design and construction of viral genomes, applying synthetic and computational biology to create viral-based products such as vaccines and viral-based therapeutics. The company targets applications in human pharma and animal health.

1 investor

Kids Public operates telemedicine consultation services for pediatric and obstetric care, as well as medical journals in these specialties, serving patients seeking remote healthcare guidance in Japan.

1 investor

symu develops a portable endo-urology simulator for medical training, housed in a wheeled case with removable urinary tract components and interchangeable kidney stones and tumors.

1 investor

Szpital na Klinach is a private hospital in Kraków, Poland, offering specialized competence centers and surgical care using minimally invasive methods such as laparoscopy, endoscopy, and robotic surgery. It provides treatment across areas including gynecology, urology, orthopedics, oncological surgery, plastic surgery, and outpatient specialist clinics.

1 investor

T.Rx Capital is a venture capital firm that invests in and helps build early-stage biotech, healthcare, and medical technology companies, focusing on drug discovery, advanced therapeutic modalities, medical devices, diagnostics, and healthcare software.

1 investor

T2S Group is a Moroccan group of companies specializing in health technology, distributing medical equipment, medical devices (imaging, biological analysis, cardiovascular), pharmaceutical products, in vitro diagnostics, and developing medical information systems such as PACS and radiology information systems. It serves healthcare providers across Morocco and several African countries, also offering clinical training, after-sales maintenance, and on-site project support.

1 investor

Tabiat provides a dedicated nursing team that monitors patients continuously and coordinates care in partnership with healthcare providers, particularly for chronic conditions like COPD. The team works alongside an AI platform to identify at-risk patients and deliver timely interventions and patient support.

1 investor

Tactile Medical develops pneumatic compression devices for at-home treatment of lymphedema and chronic venous insufficiency, supported by clinical training and insurance navigation services. The company serves patients with chronic swelling conditions who need portable, connected therapy devices.

1 investor

Tactiva Therapeutics develops immuno-oncology treatments using adoptive cell therapy approaches for cancer patients. The company leverages innovative methods in T cell engineering and gene therapy to address metastatic and gynecological cancers.

1 investor

TAG Therapeutics develops TELOBLOCK, an antisense nucleotide therapy that inhibits the DNA damage response at short or damaged telomeres to reduce cellular senescence, targeting telomere biology disorders and age-related diseases such as idiopathic pulmonary fibrosis and bone marrow failure. The company also explores ex-vivo applications to improve immune cell fitness for bone marrow transplantation and cancer immunotherapies.

1 investor

The company develops DNA aptamers—single-stranded oligonucleic acid therapeutics—using proprietary artificial base-pair technology for drug discovery and medical applications. The platform aims to create effective and safe pharmaceuticals that can be widely distributed, while also enabling applications in medical devices and diagnostics.

1 investor

Tagomics develops multimodal technologies for precision medicine and next-generation diagnostics. The company is based in Cambridge and focuses on improving patient outcomes through advanced diagnostic technologies.

1 investor

Tandem Diabetes manufactures infusion sets—tubing systems with subcutaneous delivery sites—designed for use with insulin pumps to manage diabetes. The product line includes several models (AutoSoft XC, AutoSoft 30, VariSoft, TruSteel) with varying insertion angles and tubing lengths.

1 investor

Tangible Science develops contact lens solutions designed to improve comfort and durability for wearers and to provide eye care professionals with more effective treatment options. The company serves contact lens wearers, optometrists, ophthalmologists, and lens manufacturers.

1 investor